{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-082785","form_type":"8-K","ticker":"CRVS","cik":"0001626971","company_name":"Corvus Pharmaceuticals, Inc.","filed_at":"2023-03-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.913991+00:00","generated_at":"2026-06-17T10:29:21.716464+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Corvus terminates ATM equity programs with Jefferies","bullets":["Terminated 2020 Sales Agreement (up to $50M) and 2021 Sales Agreement (up to $40M) with Jefferies LLC effective March 28, 2023.","Both at-the-market offering programs are no longer available for use.","No reason for termination provided in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-082785","json":"https://secwatch.observer/filing/0001193125-23-082785.json","markdown":"https://secwatch.observer/filing/0001193125-23-082785.md","text":"https://secwatch.observer/filing/0001193125-23-082785.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626971/000119312523082785/0001193125-23-082785-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626971/000119312523082785/d483536d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T10:29:21.716464+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c1f0b9db434a02cf97412b54c4da153487458539","claim":"Corvus Pharmaceuticals, Inc. terminated Sales Agreements with Jefferies LLC valued at At-the-Market Offering Program with aggregate offering price up to $50.0 million (2020) and up to $4 (effective 2023-03-28).","evidence_excerpt":"On March 28, 2023, the Company terminated the Sales Agreements effective immediately. As a result, the At-the-Market Offering Programs under each of the 2020 Sales Agreement and 2021 Sales Agreement are no longer available for use.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1626971/000119312523082785/0001193125-23-082785-index.htm","confidence":0.99,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Jefferies LLC"},{"label":"Value","value":"At-the-Market Offering Program with aggregate offering price up to $50.0 million (2020) and up to $4"},{"label":"Effective","value":"2023-03-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}